Trova

Antibody-oligonucleotide conjugates (AOCs) —A new wave of drug conjugates

5 (455) · € 40.00 · In Magazzino

Antibody-oligonucleotide conjugates (AOCs) —A new wave of drug conjugates
PDF) Interrogating heterogeneity of cysteine-engineered antibody-drug  conjugates and antibody-oligonucleotide conjugates by capillary zone  electrophoresis-mass spectrometry

PDF) Interrogating heterogeneity of cysteine-engineered antibody-drug conjugates and antibody-oligonucleotide conjugates by capillary zone electrophoresis-mass spectrometry

NJ Bio, Inc. — Recent Advances in ADCs

NJ Bio, Inc. — Recent Advances in ADCs

Antibody–Oligonucleotide Conjugates (AOCs) in Clinical Trials.pdf

Antibody–Oligonucleotide Conjugates (AOCs) in Clinical Trials.pdf

Wells Fargo Adjusts Price Target on Avidity Biosciences to $50 From $55,  Maintains Overweight Rating -May 11, 2023 at 11:05 am EDT

Wells Fargo Adjusts Price Target on Avidity Biosciences to $50 From $55, Maintains Overweight Rating -May 11, 2023 at 11:05 am EDT

Oligonucleotide Discovery & Delivery

Oligonucleotide Discovery & Delivery

Antibody-oligonucleotide conjugates (AOCs) —A new wave of drug conjugates

Antibody-oligonucleotide conjugates (AOCs) —A new wave of drug conjugates

A Concise, Modular Antibody–Oligonucleotide Conjugation Strategy Based on  Disuccinimidyl Ester Activation Chemistry - Li - 2019 - ChemBioChem - Wiley  Online Library

A Concise, Modular Antibody–Oligonucleotide Conjugation Strategy Based on Disuccinimidyl Ester Activation Chemistry - Li - 2019 - ChemBioChem - Wiley Online Library

Non-specific interactions of antibody-oligonucleotide conjugates with  living cells

Non-specific interactions of antibody-oligonucleotide conjugates with living cells

SEC Filing  Dyne Therapeutics, Inc.

SEC Filing Dyne Therapeutics, Inc.

JCM, Free Full-Text

JCM, Free Full-Text

Emerging new therapeutic antibody derivatives for cancer treatment

Emerging new therapeutic antibody derivatives for cancer treatment

rna-10k_20201231.htm

rna-10k_20201231.htm